Meet Selexis During Key Industry Conferences to Learn About the Latest Innovations in Cell Line DevelopmentRead More
Dirk is chief executive officer (CEO) of Selexis SA and president and CEO of JSR Life Sciences’ member company, KBI Biopharma. Previously, he served as KBI’s chief operating officer following several roles of increasing responsibility, including senior vice president of operations and site head of KBI’s Boulder, Colorado facility. He also held vice president positions in operations and business development.
Before moving to the United States in 2016, Dirk was head of external supply operations at Novartis Biologics in Basel, Switzerland, and also held leadership positions in operations, program management and business development at Sandoz Oncology Injectables in Austria, and Rentschler Biopharma in Germany. He has also led several drug substance and drug product sites through successful health authority inspections by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and Brazil’s regulatory agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA). Dirk received his Master Professional of Technical Management (CCI), an advanced training qualification of the German Chamber of Industry and Commerce (DIHK), in 2005, and his Bachelor Professional (CCI) of Pharmaceutical Technology degree in 2002. He also taught economics and operations management at the Chamber of Commerce and Industry in Ulm, Germany.